CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 8 enrolled
Drug / intervention
Ex Vivo-activated Autologous Lymph Node Lymphocytes +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02530515
NCT02530515Phase 2Completed
CompareCT.gov

Trial of Immune Reconstitution With Activated T-Cells in Patients With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center·interventional·Posted Aug 21, 2015·Updated Oct 29, 2019

In Brief

A Phase 2 clinical trial evaluating Ex Vivo-activated Autologous Lymph Node Lymphocytes and Laboratory Biomarker Analysis for Anemia and 13 related conditions. Completed, enrolled 8 participants across 1 site.

Detailed Summary

This phase II trial studies the side effects of ex vivo-activated autologous lymph node lymphocytes infusion and to see how well they work in treating patients with chronic lymphocytic leukemia. Biological therapies, such as ex vivo-activated autologous lymph node lymphocytes, use substances made from living organisms that may stimulate or suppress the immune system in different ways and stop tumor cells from growing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Cancer Fatigue, Chronic Lymphocytic Leukemia, Fever, Infectious Disorder, Lymphadenopathy, Lymphocytosis, Night Sweats, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Richter Syndrome, Secondary Malignant Neoplasm, Thrombocytopenia, Weight Loss
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 21, 2015
Enrollment StartDec 18, 2015
Primary CompletionApr 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.9 years ago

Interventions

Ex Vivo-activated Autologous Lymph Node Lymphocytesbiological

Given IV

Laboratory Biomarker Analysisother

Correlative studies